Literature DB >> 16464986

Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.

J Wipff1, Y Allanore, A Kahan, O Meyer, L Mouthon, L Guillevin, C Pierlot, E Glikmans, T Bardin, C Boileau, F Cornélis, P Dieudé.   

Abstract

The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo. Systemic sclerosis (SSc) is a connective tissue disease with some autoimmune abnormalities. The aim of our study was to test for association of the PTPN22*620W allele with SSc in a French Caucasian cohort with a case-control study of 121 patients with SSc and 103 controls. All patients and controls were genotyped for the PTPN22*R620W SNP. No association was found between the PTPN22*620W allele and SSc (7% v 9.2%, p = 0.39). The frequency of genotypes carrying at least one 620W allele was similar in both groups (13% v 17%, p = 0.38). The PTPN22*620W allele was also not associated with autoantibody patterns. Thus, the PTPN22*R620W polymorphism cannot be regarded as a genetic susceptibility factor for SSc in the French Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464986      PMCID: PMC1798267          DOI: 10.1136/ard.2005.048181

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

Review 1.  Is systemic sclerosis an antigen-driven T cell disease?

Authors:  Lazaros I Sakkas; Chris D Platsoucas
Journal:  Arthritis Rheum       Date:  2004-06

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).

Authors:  Jean-Luc Senécal; Jill Hénault; Yves Raymond
Journal:  J Rheumatol       Date:  2005-09       Impact factor: 4.666

4.  Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.

Authors:  Anne Hinks; Anne Barton; Sally John; Ian Bruce; Clive Hawkins; Christopher E M Griffiths; Rachelle Donn; Wendy Thomson; Alan Silman; Jane Worthington
Journal:  Arthritis Rheum       Date:  2005-06

5.  No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.

Authors:  M Ittah; J-E Gottenberg; A Proust; E Hachulla; X Puechal; P Loiseau; X Mariette; C Miceli-Richard
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

6.  The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis.

Authors:  Ann B Begovich; Stacy J Caillier; Heather C Alexander; Joanne M Penko; Stephen L Hauser; Lisa F Barcellos; Jorge R Oksenberg
Journal:  Am J Hum Genet       Date:  2005-01       Impact factor: 11.025

Review 7.  Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

Authors:  Shinichi Sato; Manabu Fujimoto; Minoru Hasegawa; Kazuhiko Takehara; Thomas F Tedder
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

8.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

Authors:  Chieko Kyogoku; Carl D Langefeld; Ward A Ortmann; Annette Lee; Scott Selby; Victoria E H Carlton; Monica Chang; Paula Ramos; Emily C Baechler; Franak M Batliwalla; Jill Novitzke; Adrienne H Williams; Clarence Gillett; Peter Rodine; Robert R Graham; Kristin G Ardlie; Patrick M Gaffney; Kathy L Moser; Michelle Petri; Ann B Begovich; Peter K Gregersen; Timothy W Behrens
Journal:  Am J Hum Genet       Date:  2004-07-23       Impact factor: 11.025

9.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

10.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

View more
  14 in total

Review 1.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 2.  The genetics of scleroderma: looking into the postgenomic era.

Authors:  Maureen D Mayes
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

3.  The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

4.  IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis.

Authors:  Sophie Garnier; Philippe Dieudé; Laetitia Michou; Sandra Barbet; Alice Tan; Sandra Lasbleiz; Thomas Bardin; Bernard Prum; François Cornélis
Journal:  Ann Rheum Dis       Date:  2006-12-07       Impact factor: 19.103

5.  Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene.

Authors:  Laëtitia Michou; Sandra Lasbleiz; Anne-Christine Rat; Paola Migliorini; Alejandro Balsa; René Westhovens; Pilar Barrera; Helena Alves; Céline Pierlot; Elodie Glikmans; Sophie Garnier; Jean Dausset; Carlos Vaz; Manuela Fernandes; Elisabeth Petit-Teixeira; Isabelle Lemaire; Dora Pascual-Salcedo; Stefano Bombardieri; Jan Dequeker; Timothy R Radstake; Piet Van Riel; Leo van de Putte; Antonio Lopes-Vaz; Bernard Prum; Thomas Bardin; Philippe Dieudé; François Cornélis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-19       Impact factor: 11.205

6.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

Authors:  Xiaodong Zhou; Jong Eun Lee; Frank C Arnett; Momiao Xiong; Min Young Park; Yeon Kyeong Yoo; Eun Soon Shin; John D Reveille; Maureen D Mayes; Jin Hyun Kim; Ran Song; Ji Yong Choi; Ji Ah Park; Yun Jong Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Rheum       Date:  2009-12

Review 8.  PTPN22: its role in SLE and autoimmunity.

Authors:  Sharon A Chung; Lindsey A Criswell
Journal:  Autoimmunity       Date:  2007-12       Impact factor: 2.815

9.  Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.

Authors:  L M Diaz-Gallo; P Gourh; J Broen; C Simeon; V Fonollosa; N Ortego-Centeno; S Agarwal; M C Vonk; M Coenen; G Riemekasten; N Hunzelmann; R Hesselstrand; F K Tan; J D Reveille; S Assassi; F J García-Hernandez; P Carreira; M T Camps; A Fernandez-Nebro; P Garcia de la Peña; T Nearney; D Hilda; M A González-Gay; P Airo; L Beretta; R Scorza; A Herrick; J Worthington; A Pros; I Gómez-Gracia; L Trapiella; G Espinosa; I Castellvi; T Witte; F de Keyser; M Vanthuyne; M D Mayes; T R D J Radstake; F C Arnett; J Martin; B Rueda
Journal:  Ann Rheum Dis       Date:  2010-12-03       Impact factor: 19.103

Review 10.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.